Table of Contents
- Cinchonine (CAS 118-10-5) Overview
- Technical Specifications & Comparative Analysis
- Key Applications & Industry Uses
- Pharmaceutical Research Case Study
- Asymmetric Synthesis Application
- Antimalarial Drug Development – ABC Pharma
- Chiral Catalyst Production – XYZ Chemicals
- Request Customized Solutions
Cinchonine (CAS 118-10-5) Overview
Basic Chemical Properties
| Parameter | Specification |
|---|---|
| CAS Number | 118-10-5 |
| Molecular Formula | C19H22N2O |
| Molecular Weight | 294.39 g/mol |
| Appearance | White crystalline powder |
| Purity | ≥98% (HPLC) |
| Melting Point | 264-266°C |
| Storage Conditions | 2-8°C in airtight container |
Technical Specifications & Comparative Analysis
| Feature | Cinchonine | Cinchonidine | Quinine |
|---|---|---|---|
| Stereochemistry | 8R,9S | 8S,9R | 8S,9R |
| Optical Rotation | +229° (c=1, CHCl3) | -109° (c=0.5, EtOH) | -158° (c=2, EtOH) |
| Solubility | Moderate in ethanol | Poor in water | Soluble in hot water |
| Pharma Applications | Synergistic antimalarial | Alkaloid research | Primary therapeutic agent |
Key Applications & Industry Uses
Pharmaceutical Applications
1. Malaria Treatment Adjuvant: Enhances quinine efficacy through pharmacokinetic modulation
2. Cardiac Research: Modulates ion channels in electrophysiology studies
3. Neurological Studies: GABA receptor interaction analysis
Chemical Synthesis Uses
1. Asymmetric catalysis in chiral molecule synthesis
2. Resolution agent for enantiomeric separation
3. Organocatalyst in Michael addition reactions
Pharmaceutical Research Case Study
Project: Antimalarial Combination Therapy Development
1. Challenge: Reduce quinine dosage while maintaining efficacy
2. Solution: 1:3 cinchonine-quinine co-formulation
3. Result: 40% dosage reduction with equivalent parasite clearance rate
4. Process: In vitro hemozoin inhibition assay → murine model validation
Asymmetric Synthesis Application
Process: Enantioselective Aldol Reaction
1. Substrate: Prochiral ketones
2. Catalyst: Cinchonine-derived thiourea (0.5 mol%)
3. Conditions: Toluene, -20°C, 24h
4. Outcome: 92% yield, 88% ee
5. Scale-up: Successful kilogram-scale production
ABC Pharma – Antimalarial Development
| Parameter | Detail |
|---|---|
| Client Profile | Top 10 global antimalarial producer |
| Challenge | High toxicity in existing formulations |
| Solution | Cinchonine-based combination therapy |
| Implementation | GMP-grade supply, technical support |
| Result | 30% toxicity reduction, FDA fast-track approval |
XYZ Chemicals – Catalyst Production
| Parameter | Detail |
|---|---|
| Client Profile | Specialty chemical manufacturer |
| Challenge | Low enantioselectivity in API synthesis |
| Solution | Custom cinchonine catalyst system |
| Implementation | Bulk supply with purity certification |
| Result | 95% ee achieved, production cost reduced 25% |
Request Customized Solutions
Technical & Commercial Consultation
Contact our alkaloid specialists:
Email: info@vivalr.com
Tel: (86) 15866781826
Service Scope:
1. Custom purity specifications (98-99.9%)
2. Bulk quantities (kg to ton scale)
3. Regulatory support (DMF, CEP files)
4. Application development services



评论
目前还没有评论。